Eisai and Nobelpharma Sign License Agreement for GLIADEL(R) WAFER in Japan

  Tokyo, Apr 6, 2009 - (JCN Newswire) - Eisai Co., Ltd. announced today that Eisai entered into a license agreement with Nobelpharma Co., Ltd. in which Eisai gives Norbelpharma the exclusive right to develop and commercialise GLIADEL(R) Wafer (polifeprosan 20 with carmustine implant) in Japan, while retaining an option right to obtain the exclusive commercialisation right of GLIADEL Wafer in Japan once the NDA has been filed for approval.  

Sydney

  [ Change ]
 
Today

Max: 19°
Shower or two.
Tomorrow

Min: 13°
Max: 20°
Possible shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online